SBIR-STTR Award

Whole-Brain Fluorescence and Brightfield Imaging At Single-Cell Level
Award last edited on: 12/24/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIA
Total Award Amount
$3,339,868
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Pixuan 'Joe' Zhou

Company Information

DMetrix Inc

9030 South Rita Road Suite 389
Tucson, AZ 85747
   (520) 722-9510
   sales@dmetrix.com
   www.dmetrix.com
Location: Single
Congr. District: 02
County: 

Phase I

Contract Number: 1R44AG035446-01
Start Date: 9/1/10    Completed: 7/31/12
Phase I year
2010
Phase I Amount
$492,936
The goal of this project is to develop an open and flexible imaging platform capable of rapid, 0.5- 5 ,m pixel resolution image capture of large-area histology sections (up to 125 mm by 175 mm), in brightfield and by epi-fluorescence optical sectioning. The project involves state-of-the- art instrumentation development coupled with application programming interfaces (APIs) to provide users with a reliable, multi-purpose research instrument. The development of a high speed large format imaging system will dramatically accelerate investigations such as amyloid protein studies for Alzheimer's disease or the expression of immediate-early genes (IEG) in understanding of the cellular basis of cognition. The number of digital-imaging system options decreases dramatically as the size of histology sections outgrows 1"" W 3"" glass slides. Further, because the current vendors are concentrating on digitizing anatomic pathology, their systems tend to be closed and inflexible to accommodate the regulatory constraints on medical devices. The market opportunity that DMetrix has identified is a robust and reliable commercial imaging platform with the flexibility and customization options valued by research groups. The project is divided into two Phases, punctuated by a demonstration of quantitative criteria, related to instrument and software performance. The primary goal of Phase I is the demonstration of feasibility of the large-area, rapid imaging instrument for brightfield and epi-fluorescence. A second goal is an image-viewer application that allows practical interaction with terabyte image data sets as will be generated by the instrument. The Specific Aims of Phase II are selected to lead to a product launch at the conclusion of the project. The Phase II Aims include the development of a ""V6,"" six-imaging-module slide scanner, image- management software, and an advanced image-viewer application. Further, the work in Phase II leverages the core expertise of DMetrix, namely the development of fast, parallel image-capture instruments. A significant part of the Phase II effort will be directed at making the proposed instrument manufacturable at a minimum cost of goods sold (COGS) and optimized for serviceability. DMetrix has teamed on this project with an interdisciplinary group of academic experts from the University of Arizona. The University team includes Dr. Carol Barnes from the McKnight Brain Institute, Dr. Ted Trouard, Department of Radiology and Biomedical Engineering, and Dr. Gene Alexander, Director of the Brain Imaging, Behavior and Aging Lab in the Department of Psychology. These University of Arizona scientists represent a diverse sampling of the broad impact of the proposed imaging platform on neuroscience research. , ,

Public Health Relevance:
Understanding the circuits in the brain responsible for cognition, emotion and action is a critical first step to developing treatments for important neurological disorders, such as Alzheimer's disease, Parkinson's disease, temporal lobe epilepsy, depression, and schizophrenia. Collectively, these disorders affect over 20 million Americans. Our long-range goal is to develop a system that has wide application across the field of neuroscience that will enable experiments impeded in the past by technological limitations, to span mouse models of disease to rat and nonhuman primate models of normal aging. This knowledge may bring us closer to optimizing neural function in health, and developing new therapies for patients disabled by neurological disease.

Thesaurus Terms:
3d Modeling;Affect;Aging;Alzheimer;Alzheimer Disease;Alzheimer Sclerosis;Alzheimer Syndrome;Alzheimer's;Alzheimer's Disease;Alzheimers Dementia;Alzheimers Disease;American;Ammon Horn;Amyloid Proteins;Anatomic;Anatomical Sciences;Anatomy;Anti-Sense Probes;Area;Arizona;Arts;Award;Behavior;Biomedical Engineering;Body Tissues;Brain;Brain Imaging;Card-20(22)-Enolide, 3,12,14-Trihydroxy-, (3beta,5beta,12beta)-;Cells;Characteristics;Cognition;Color;Common Rat Strains;Communities;Computer Programs;Computer Software Tools;Computer Software;Confocal Microscopy;Cornu Ammonis;Coupled;Custom;Data;Data Banks;Data Base Management;Data Bases;Data Set;Databank, Electronic;Databanks;Database, Electronic;Databases;Dataset;Dementia, Alzheimer Type;Dementia, Primary Senile Degenerative;Dementia, Senile;Depression;Detection;Development;Digoxigenin;Disabled Persons;Disabled Population;Disease;Disorder;Emotions;Encephalon;Encephalons;Engineering;Engineerings;Equipment;Fluorescence;Gene Products, Rna;Genes;Glass;Goals;Handicapped;Health;Hippocampus;Hippocampus (Brain);Histology;Idiopathic Parkinson Disease;Image;Image Analyses;Image Analysis;Immediate-Early Genes;Individual;Institutes;Instrumentation, Other;Investigation;Investigators;Knowledge;Label;Lanadigenin;Lateral;Lead;Lewy Body Parkinson Disease;Licensing;Light Microscope;Mammals, Mice;Mammals, Primates;Mammals, Rats;Market Research;Marketing;Measures;Medical Device;Mental Depression;Metadata;Mice;Microscope;Microscopic;Modeling;Murine;Mus;Nervous System Diseases;Nervous System, Brain;Neurologic Disorders;Neurological Disorders;Neurophysiology - Biologic Function;Neurosciences;Neurosciences Research;Optics;Paralysis Agitans;Parkinson;Parkinson Disease;Parkinson's;Parkinson's Disease;Parkinsons Disease;Pathology;Patients;Pb Element;People With Disabilities;Performance;Persons With Disabilities;Phase;Primary Parkinsonism;Primary Senile Degenerative Dementia;Primates;Probes, Antisense;Programs (Pt);Programs [publication Type];Psychology;Rna;Rna, Non-Polyadenylated;Roc Analysis;Radiology;Radiology Specialty;Radiology, General;Rat;Rattus;Reading;Research;Research Personnel;Researchers;Resolution;Ribonucleic Acid;Sales;Sample Size;Sampling;Scanning;Schizophrenia;Schizophrenic Disorders;Science;Science Of Anatomy;Scientist;Senescence;Slide;Software;Software Tools;Solutions;Speed;Speed (Motion);System;System, Loinc Axis 4;Technology;Temporal Lobe Epilepsy;Time;Tissues;Tools, Software;Universities;Vendor;Work;Writing;Anatomy;Base;Bioengineering;Bioengineering/Biomedical Engineering;Brain Tissue;Brain Visualization;Clinical Data Repository;Clinical Data Warehouse;College;Computer Imaging;Computer Program/Software;Cost;Data Repository;Dementia Of The Alzheimer Type;Dementia Praecox;Design;Designing;Digital Imaging;Disabled;Disabled People;Disease/Disorder;Experience;Experiment;Experimental Research;Experimental Study;Flexibility;Fluorescence Imaging;Heavy Metal Pb;Heavy Metal Lead;Hippocampal;Image Evaluation;Imaging;Imaging Modality;Innovate;Innovation;Innovative;Instrument;Instrumentation;Interest;Mouse Model;Nervous System Disorder;Neural Function;Neurological Disease;Non-Human Primate;Nonhuman Primate;Normal Aging;Operation;Primary Degenerative Dementia;Product Development;Programs;Prototype;Public Health Relevance;Relational Database;Research Study;Schizophrenic;Senescent;Senile Dementia Of The Alzheimer Type;Sub Micron;Submicron;Three-Dimensional Modeling

Phase II

Contract Number: 5R44AG035446-02
Start Date: 9/1/10    Completed: 7/31/12
Phase II year
2011
(last award dollars: 2014)
Phase II Amount
$2,846,932

The goal of this project is to develop an open and flexible imaging platform capable of rapid, 0.5- 5 m pixel resolution image capture of large-area histology sections (up to 125 mm by 175 mm), in brightfield and by epi-fluorescence optical sectioning. The project involves state-of-the- art instrumentation development coupled with application programming interfaces (APIs) to provide users with a reliable, multi-purpose research instrument. The development of a high speed large format imaging system will dramatically accelerate investigations such as amyloid protein studies for Alzheimer's disease or the expression of immediate-early genes (IEG) in understanding of the cellular basis of cognition. The number of digital-imaging system options decreases dramatically as the size of histology sections outgrows 1"" W 3"" glass slides. Further, because the current vendors are concentrating on digitizing anatomic pathology, their systems tend to be closed and inflexible to accommodate the regulatory constraints on medical devices. The market opportunity that DMetrix has identified is a robust and reliable commercial imaging platform with the flexibility and customization options valued by research groups. The project is divided into two Phases, punctuated by a demonstration of quantitative criteria, related to instrument and software performance. The primary goal of Phase I is the demonstration of feasibility of the large-area, rapid imaging instrument for brightfield and epi-fluorescence. A second goal is an image-viewer application that allows practical interaction with terabyte image data sets as will be generated by the instrument. The Specific Aims of Phase II are selected to lead to a product launch at the conclusion of the project. The Phase II Aims include the development of a ""V6

Thesaurus Terms:
3d Modeling;Affect;Aging;Alzheimer;Alzheimer Type Dementia;Alzheimer Disease;Alzheimer Sclerosis;Alzheimer Syndrome;Alzheimer's;Alzheimer's Disease;Alzheimers Dementia;Alzheimers Disease;American;Ammon Horn;Amyloid Proteins;Anatomic;Anatomical Sciences;Anatomy;Anti-Sense Probes;Antisense Probes;Area;Arizona;Award;Behavior;Biomedical Engineering;Body Tissues;Brain;Brain Nervous System;Brain Imaging;Card-20(22)-Enolide, 3,12,14-Trihydroxy-, (3beta,5beta,12beta)-;Cells;Characteristics;Cognition;Color;Common Rat Strains;Communities;Computer Software Tools;Computer Software;Confocal Microscopy;Cornu Ammonis;Coupled;Custom;Data;Data Banks;Data Base Management;Data Bases;Data Set;Databanks;Databases;Dataset;Detection;Development;Digoxigenin;Disabled Persons;Disabled Population;Disease;Disorder;Electronic Databank;Electronic Database;Emotions;Encephalon;Engineering;Equipment;Fluorescence;General Radiology;Genes;Glass;Goals;Handicapped;Health;Hippocampus;Hippocampus (Brain);Histology;Idiopathic Parkinson Disease;Image;Image Analyses;Image Analysis;Immediate-Early Genes;Individual;Institutes;Investigation;Investigators;Knowledge;Loinc Axis 4 System;Label;Lanadigenin;Lateral;Lead;Lewy Body Parkinson Disease;Licensing;Light Microscope;Market Research;Marketing;Measures;Medical Device;Mental Depression;Metadata;Mice;Mice Mammals;Microscope;Microscopic;Modeling;Murine;Mus;Nervous System Diseases;Neurologic Disorders;Neurological Disorders;Neurophysiology - Biologic Function;Neurosciences;Neurosciences Research;Non-Polyadenylated Rna;Optics;Paralysis Agitans;Parkinson;Parkinson Disease;Parkinson's;Parkinson's Disease;Parkinsons Disease;Pathology;Patients;Pb Element;People With Disabilities;Performance;Persons With Disabilities;Phase;Primary Parkinsonism;Primary Senile Degenerative Dementia;Primates;Primates Mammals;Psychology;Rna;Rna Gene Products;Radiology;Radiology Specialty;Rat;Rats Mammals;Rattus;Reading;Research;Research Personnel;Researchers;Resolution;Ribonucleic Acid;Sales;Sample Size;Sampling;Scanning;Schizophrenia;Schizophrenic Disorders;Science;Scientist;Slide;Software;Software Tools;Solutions;Speed;Speed (Motion);System;Technology;Temporal Lobe Epilepsy;Time;Tissues;Universities;Vendor;Work;Writing;Base;Bioengineering;Brain Tissue;Brain Visualization;Clinical Data Repository;College;Collegiate;Computer Imaging;Computer Program/Software;Cost;Data Repository;Database Management;Dementia Of The Alzheimer Type;Dementia Praecox;Depression;Design;Designing;Developmental;Digital Imaging;Disabled;Disabled People;Disease/Disorder;Experience;Experiment;Experimental Research;Experimental Study;Flexibility;Flexible;Fluorescence Imaging;Heavy Metal Pb;Heavy Metal Lead;Hippocampal;Image Evaluation;Imaging;Imaging Method;Imaging Modality;Innovate;Innovation;Innovative;Instrument;Instrumentation;Interest;Mouse Model;Nervous System Disorder;Neural Function;Neurological Disease;Non-Human Primate;Nonhuman Primate;Normal Aging;Operation;Optical;Primary Degenerative Dementia;Product Development;Programs;Prototype;Public Health Relevance;Research Study;Schizophrenic;Senile Dementia Of The Alzheimer Type;Sub Micron;Submicron;Three-Dimensional Modeling